CONTE, Mariarosaria
 Distribuzione geografica
Continente #
EU - Europa 4.482
NA - Nord America 2.417
AS - Asia 1.815
SA - Sud America 315
Continente sconosciuto - Info sul continente non disponibili 192
AF - Africa 24
OC - Oceania 3
Totale 9.248
Nazione #
RU - Federazione Russa 2.794
US - Stati Uniti d'America 2.345
SG - Singapore 592
IT - Italia 558
IE - Irlanda 425
CN - Cina 386
BR - Brasile 267
HK - Hong Kong 264
VN - Vietnam 228
GB - Regno Unito 153
DE - Germania 136
UA - Ucraina 129
KR - Corea 96
FI - Finlandia 76
BD - Bangladesh 59
IN - India 52
FR - Francia 43
SE - Svezia 41
TR - Turchia 39
GR - Grecia 32
CA - Canada 31
NL - Olanda 24
AR - Argentina 20
JP - Giappone 19
ID - Indonesia 15
MX - Messico 15
AT - Austria 13
ES - Italia 13
EC - Ecuador 11
ZA - Sudafrica 10
BE - Belgio 9
IQ - Iraq 9
PK - Pakistan 9
UZ - Uzbekistan 8
CR - Costa Rica 7
LT - Lituania 6
PL - Polonia 6
AE - Emirati Arabi Uniti 5
PT - Portogallo 5
SI - Slovenia 5
VE - Venezuela 5
CL - Cile 4
CO - Colombia 4
IR - Iran 4
PH - Filippine 4
SA - Arabia Saudita 4
TH - Thailandia 4
AZ - Azerbaigian 3
BG - Bulgaria 3
BS - Bahamas 3
EU - Europa 3
JM - Giamaica 3
KE - Kenya 3
MA - Marocco 3
MY - Malesia 3
NP - Nepal 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
AL - Albania 2
BO - Bolivia 2
DZ - Algeria 2
EG - Egitto 2
HN - Honduras 2
IL - Israele 2
NZ - Nuova Zelanda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AU - Australia 1
BB - Barbados 1
BM - Bermuda 1
BW - Botswana 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GY - Guiana 1
HU - Ungheria 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
LC - Santa Lucia 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MN - Mongolia 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PE - Perù 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
Totale 9.060
Città #
Moscow 980
Dublin 420
Singapore 287
Santa Clara 271
San Jose 265
Hong Kong 261
Jacksonville 206
Ashburn 180
Chandler 178
Council Bluffs 129
Beijing 107
Seoul 92
Naples 77
Caserta 72
Ho Chi Minh City 62
Princeton 53
Milan 50
Hanoi 46
Medford 42
Hefei 40
Roxbury 38
Dallas 37
Ann Arbor 35
Helsinki 33
Munich 32
Boardman 31
Dong Ket 30
Los Angeles 30
Aversa 28
Bengaluru 27
Bremen 25
New York 25
Wilmington 25
Rome 23
São Paulo 21
The Dalles 19
San Mateo 17
Da Nang 16
Napoli 15
Cambridge 14
Rio de Janeiro 14
Haiphong 13
Des Moines 12
Houston 12
Orem 12
London 11
Mountain View 11
Nuremberg 11
Woodbridge 11
Ercolano 10
Memphis 10
Brussels 9
Miano 9
Brasília 8
Brooklyn 8
Nanjing 8
Phoenix 8
Seattle 8
Tashkent 8
Buffalo 7
Chennai 7
Cicciano 7
Hillsboro 7
Hải Dương 7
Jakarta 7
Paris 7
Vienna 7
Volla 7
Belo Horizonte 6
Biên Hòa 6
Bologna 6
Boston 6
Columbus 6
Mumbai 6
North Bergen 6
Salvador 6
San José 6
Shanghai 6
Thái Bình 6
Thái Nguyên 6
Tokyo 6
Turku 6
Viterbo 6
Amsterdam 5
Atlanta 5
Bacoli 5
Changsha 5
Chicago 5
Düsseldorf 5
Frankfurt am Main 5
Giugliano in Campania 5
Lappeenranta 5
Manchester 5
Miami 5
Montreal 5
Quito 5
Shenyang 5
Tianjin 5
Warsaw 5
Aachen 4
Totale 4.769
Nome #
Bisphenol A induces cell cycle arrest in primary and prostate cancer cells through EGFR/ERK/p53 signaling pathway activation. 314
C-Myc modulation and acetylation is a key HDAC inhibitor target in cancer 230
The clinical value of HDAC2 and the p53-dependent signalling pathway in colorectal cancer 212
Forskolin potentiates the effects of GSKJ4 in human acute myeloid leukemia cells through Protein Kinase A pathway 207
CBX2 shapes chromatin accessibility promoting AML via p38 MAPK signaling pathway 187
CBX3 as a prognostic biomarker in lung cancer 185
Feijoa sellowiana derived natural Flavone exerts anti-cancer action displaying HDAC inhibitory activities 185
Analysis of chromatin-nuclear receptor interactions by laser-chromatin immunoprecipitation. 183
Different Approaches to Unveil Biomolecule Configurations and Their Mutual Interactions 181
ARHGEF3 controls HDACi-induced differentiation via RhoA-dependent pathways in acute myeloid leukemias. 178
Molecular analysis of the apoptotic effects of BPA in acute myeloid leukemia cells 172
Combined HAT/EZH2 modulation leads to cancer-selective cell death 169
Exploring the Role of CBX3 as a Potential Therapeutic Target in Lung Cancer 166
Cytotoxic Potential of the Marine Diatom Thalassiosira rotula: Insights into Bioactivity of 24-Methylene Cholesterol 163
Context-selective death of acute myeloid leukemia cells triggered by the novel hybrid retinoid-HDAC inhibitor MC2392. 162
BARD1 is a target of miR-19a and miR-19b: a new selective epigenetic therapy for acute myeloid lekaemias? 162
Epigenetic-based therapy: From single- to multi-target approaches 158
TNF-related apoptosis-inducing ligand: Signalling of a 'smart' molecule 151
HDAC2 deregulation in tumorigenesis is causally connected to repression of immune modulation and defense escape. 149
Time-resolved analysis of DNA-protein interactions in living cells by UV laser pulses 148
Designing Novel Dual Transglutaminase 2 / Histone Deacetylase Inhibitors Effective in Halting Neuronal Death 146
Selective class II HDAC inhibitors impair myogenesis by modulating the stability and activity of HDAC-MEF2 complexes 145
Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent to Combat Alzheimer's Disease 145
Unlocking the power of empagliflozin: Rescuing inflammation in hyperglycaemia- exposed human cardiomyocytes through comprehensive multi-level analysis 144
Pan-Histone Demethylase Inhibitors Simultaneously Targeting Jumonji C and Lysine Specific Demethylases Display High Anticancer Activities. 143
Developing novel non-hydroxamate histone deacetylase inhibitors: The chelidamic warhead 143
Inverse FASN and LDHA correlation drives metabolic resistance in breast cancer 142
SIRT1 activation promotes energy homeostasis and reprograms liver cancer metabolism 142
Novel cinnamyl hydroxyamides and 2-aminoanilides as histone deacetylase inhibitors: apoptotic induction and cytodifferentiation activity 141
Advanced Assays in Epigenetics 139
FEIJOA SELLOWIANA DERIVED NATURAL FLAVONE EXERTS ANTI-CANCER ACTION DISPLAYING HDAC INHIBITORY ACTIVITIES 138
Synthesis and Biological Validation of Novel Synthetic Histone/Protein Methyltransferase Inhibitors 136
Sarcoma Common MHC-I Haplotype Restricts Tumor-Specific CD8+ T Cell Response 135
Electrostatically driven scalable synthesis of MoS2-graphene hybrid films assisted by hydrophobins 135
Unravelling the impact of the chromobox proteins in human cancers 132
HDAC inhibitors as epigenetic regulators for cancer immunotherapy 131
Editorial: Chemical Innovative Approaches in Cancer Molecular Medicine and Translational Clinical Research 131
METTL16-mediated inhibition of MXD4 promotes leukemia through activation of the MYC-MAX axis 130
Forskolin sensitizes human acute myeloid leukemia cells to H3K27me2/3 demethylases GSKJ4 inhibitor via Protein Kinase A 129
Quinoline-Based p300 Histone Acetyltransferase Inhibitors with Pro-apoptotic Activity in Human Leukemia U937 Cells. 128
Indole-derived Psammaplin A Analogs as Epigenetic Modulators With Multiple Inhibitory Activities. 124
Genetic mutations in epigenetic modifiers as therapeutic targets in acute myeloid leukemia. 123
HDAC Inhibitors Repress BARD1 Isoform Expression in Acute Myeloid Leukemia Cells via Activation of miR-19a and/or b. 121
Pyrrole-Based Hydroxamates and 2-Aminoanilides: Histone Deacetylase Inhibition and Cellular Activities 120
In-Depth Exploration of Radiation-Induced Cell Death Mechanisms in Tumor 119
Genista sessilifolia DC. extracts induce apoptosis across a range of cancer cell lines. 118
Distribution and Level of Bioactive Monoacylglycerols in 12 Marine Microalgal Species 116
Targeting HDACs in diseases: where are we? 112
Nonlinear protein – nucleic acid crosslinking induced by femtosecond UV laser pulses in living cells 112
Marine-Derived Secondary Metabolites as Promising Epigenetic Bio-Compounds for Anticancer Therapy 112
Targeting HDAC2-Mediated Immune Regulation to Overcome Therapeutic Resistance in Mutant Colorectal Cancer 111
Multi-omics profiling reveals a distinctive epigenome signature for high-risk acute promyelocytic leukemia 110
Molecular pathways: the complexity of the epigenome in cancer and recent clinical advances. 108
Relevance of AIF/CypA Lethal Pathway in SH-SY5Y Cells Treated with Staurosporine 107
Synthesis of Benzamides Related to Anacardic Acid and Their Histone Acetyltransferase (HAT) Inhibitory Activities 105
Functions, Aberrations, and Advances for Chromatin Modulation in Cancer 105
Recent Advancement in Anticancer Compounds from Marine Organisms: Approval, Use and Bioinformatic Approaches to Predict New Targets 104
Structure-activity relationships, biological evaluation and structural studies of novel pyrrolonaphthoxazepines as antitumor agents 103
The KDM inhibitor GSKJ4 triggers CREB down-regulation via a protein kinase A and proteasome dependent mechanism in human acute myeloid leukemia cells 102
HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation 96
HDAC2-dependent miRNA signature in acute myeloid leukemia 95
Monoacylglycerides from the Diatom Skeletonema marinoi Induce Selective Cell Death in Cancer Cells 93
The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin 91
Properly Substituted Cyclic Bis-(2-bromobenzylidene) Compounds Behaved as Dual p300/CARM1 Inhibitors and Induced Apoptosis in Cancer Cells 87
Role of the silencing of genes that encode for HDAC1 and HDAC2 in the cell line of acute myeloid leukaemia U937 86
Novel Pyridine-Based Hydroxamates and 2′-Aminoanilides as Histone Deacetylase Inhibitors: Biochemical Profile and Anticancer Activity 83
Lysine demethylase (KDM) inhibitors for the treatment of cancer: a patent review (2015-present) 68
Totale 9.248
Categoria #
all - tutte 30.719
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.719


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022300 0 0 0 5 108 3 2 11 21 29 18 103
2022/2023790 68 31 22 55 67 58 1 39 408 6 17 18
2023/2024260 28 10 9 16 85 21 4 1 1 9 27 49
2024/20251.119 7 7 80 23 174 138 204 113 91 118 100 64
2025/20264.887 205 216 236 287 364 2.629 220 189 182 132 108 119
2026/2027783 47 138 269 329 0 0 0 0 0 0 0 0
Totale 9.248